SecBot SecBot
SECBOTREPLAY Home › Report › MRNA

MRNA · CEO Stephane Bancel filed a Form 144 on August 5, 2026, indicating…

Moderna, Inc. · 144 filed Aug 5, 2026 at 13:02 ET

At the news

BEARISHIMPACT 6/10

144 filed Aug 5, 2026 at 13:02 ET

CEO Stephane Bancel filed a Form 144 on August 5, 2026, indicating intent to sell 499,246 shares of Moderna common stock, valued at approximately $28.96 million. The shares were acquired via stock option exercise, and the sale is planned through Fidelity Brokerage Services. This is a material insider sale by the CEO, representing a notable portion of his holdings, and may signal a lack of near-term confidence or a planned diversification event.

  • CEO Stephane Bancel filed a Form 144 to sell 499,246 shares of Moderna common stock.
  • The proposed sale value is approximately $28,956,268 based on the filing date (August 5, 2026).
  • Shares were acquired via stock option exercise on the same date (August 5, 2026).
  • The sale is planned through Fidelity Brokerage Services LLC.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access